Judite Raquel Martins Coimbra

Therapeutic potential of glutaminyl cyclases: current status and emerging trends

Judite R.M. Coimbra; Paula I. Moreira; Armanda E. Santos; Jorge A.R. Salvador, Drug Discovery Today. 103644 - 103644. 2023. http://dx.doi.org/10.1016/j.drudis.2023.103644 . 10.1016/j.drudis.2023.103644 . Drug Discovery Today

A patent review of glutaminyl cyclase inhibitors (2004–present)

Coimbra, Judite RM; Salvador, Jorge A.R., Expert Opinion on Therapeutic Patents. 809 - 836. 9. 31. 2021. http://dx.doi.org/10.1080/13543776.2021.1917549 . 10.1080/13543776.2021.1917549 . Expert Opinion on Therapeutic Patents

New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AßPPß Cleavage Decreasing Amyloid-ß Production and Accumulation in Alzheimer's Disease Models

Coimbra, Judite RM, Journal of Alzheimer's Disease. 2020. http://doi.org/10.3233/JAD-200381 . 10.3233/JAD-200381 . Journal of Alzheimer's Disease

Combining Virtual Screening Protocol and In Vitro Evaluation towards the Discovery of BACE1 Inhibitors

Judite R. M. Coimbra; Salete J. Baptista; Teresa C. P. Dinis; Maria M. C. Silva; Paula I. Moreira; Armanda E. Santos; Jorge A. R. Salvador, Biomolecules. 535 - 535. 4. 10. 2020. https://doi.org/10.3390/biom10040535 . 10.3390/biom10040535 . Biomolecules

An overview of glutaminyl cyclase inhibitors for Alzheimer’s disease

Judite RM Coimbra; Pedro JM Sobral; Armanda E Santos; Paula I Moreira; Jorge AR Salvador, Future Medicinal Chemistry. 2019. https://doi.org/10.4155/fmc-2019-0163 . 10.4155/fmc-2019-0163 . Future Medicinal Chemistry